This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Adient (ADNT) Surges 10.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Adient (ADNT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
ADNTNegative Net Change EVGOPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Innovative Solutions and Support (ISSC) Surges 15.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Innovative Solutions and Support (ISSC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
ISSCPositive Net Change RKLBPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strategy (MSTR) Moves 3.7% Higher: Will This Strength Last?
by Zacks Equity Research
Strategy (MSTR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
MSTRPositive Net Change STEPPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
LyondellBasell (LYB) Surges 6.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
LyondellBasell (LYB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
LYBPositive Net Change TROXNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Nutrien (NTR): Can Its 7.9% Jump Turn into More Strength?
by Zacks Equity Research
Nutrien (NTR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
NTRNegative Net Change CFPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
TTM (TTMI) Moves 19.7% Higher: Will This Strength Last?
by Zacks Equity Research
TTM (TTMI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
TTMIPositive Net Change OLEDNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
BNP Paribas SA (BNPQY) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
BNPQYPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Digital Realty Trust (DLR) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
DLRPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Novavax (NVAX) Moves 11.9% Higher: Will This Strength Last?
by Zacks Equity Research
Novavax (NVAX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
NVAXPositive Net Change OCGNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Plexus (PLXS): Can Its 7.5% Jump Turn into More Strength?
by Zacks Equity Research
Plexus (PLXS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
PLXSPositive Net Change CLSPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Kennametal (KMT) Surges 8.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Kennametal (KMT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
KMTNegative Net Change SWKPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Ascendis Pharma (ASND) Surges 3.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
Ascendis Pharma (ASND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ASNDNegative Net Change CHRSNegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Roblox (RBLX) Surges 10.5%: Is This an Indication of Further Gains?
by Zacks Equity Research
Roblox (RBLX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
RBLXPositive Net Change MGMNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Option Care (OPCH) Moves 8.4% Higher: Will This Strength Last?
by Zacks Equity Research
Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
OPCHNegative Net Change USPHNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Gold.com (GOLD) Surges 9.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
Gold.com (GOLD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
GOLDPositive Net Change PRAAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Plains All American Pipeline (PAA) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PAAPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Sunrun (RUN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
RUNNegative Net Change
daily-movers moving-average-crossover stocks-moving-today
Sunrun (RUN) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?
RUNNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Day One Biopharmaceuticals (DAWN) Surges 26.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Day One Biopharmaceuticals (DAWN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
DAWNNegative Net Change IDYANegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Lindblad Expeditions (LIND) Soars 12.3%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Lindblad Expeditions (LIND) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
LINDNegative Net Change FUNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
A.P. Moller-Maersk (AMKBY) Moves 7.7% Higher: Will This Strength Last?
by Zacks Equity Research
A.P. Moller-Maersk (AMKBY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
AMKBYNegative Net Change CCECPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Nexa Resources (NEXA) Moves 6.2% Higher: Will This Strength Last?
by Zacks Equity Research
Nexa Resources (NEXA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
NEXANegative Net Change RSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
M/A-Com (MTSI) Surges 13.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
M/A-Com (MTSI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MTSIPositive Net Change MPWRPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
RxSight (RXST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
RXSTPositive Net Change IDXXPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
OrthoPediatrics (KIDS) Moves 9.8% Higher: Will This Strength Last?
by Zacks Equity Research
OrthoPediatrics (KIDS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
KIDSNegative Net Change OPKNo Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today